Campbell's (CPB) Leaves The S&P 500 As It Debuts Gluten Free Chicken Noodle Soup
Campbell's Company CPB | 0.00 |
- Campbell's (NasdaqGS:CPB) has been removed from the S&P 500 index, marking a change in its market classification.
- The company has launched its first gluten free condensed chicken noodle soup in partnership with Banza.
- The gluten free product extends Campbell's flagship soup line to consumers avoiding traditional wheat based pasta.
Campbell's now sits outside the S&P 500, a shift that can change how some index linked funds and benchmarks interact with the stock. Shares recently closed at $21.21, with the stock down 23.5% year to date and down 30.2% over the past year. Over a 3 year period, the stock is down 47.9%, and down 43.9% over 5 years, which may shape how you think about its recent moves.
At the same time, Campbell's is extending its core soup franchise with a gluten free condensed chicken noodle soup made with Banza pasta, targeting consumers looking to avoid gluten. For investors, this pairing of an index exit with a product launch frames the next chapter for NasdaqGS:CPB as one in which brand strength and product decisions may matter more than index membership alone.
Stay updated on the most important news stories for Campbell's by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Campbell's.
Quick Assessment
- ⚖️ Price vs Analyst Target: Campbell's trades at US$21.21, close to the US$21.44 analyst target, so expectations look broadly aligned.
- ✅ Simply Wall St Valuation: The stock is flagged as undervalued, trading about 61.9% below an estimated fair value.
- ✅ Recent Momentum: A 3.1% gain over 30 days contrasts with longer term share price declines and may reflect a shift in sentiment.
There's only one way to know the right time to buy, sell or hold Campbell's. Head to Simply Wall St's company report for the latest analysis of Campbell's's Fair Value.
Key Considerations
- 📊 Removal from the S&P 500 can affect passive fund ownership of Campbell's. At the same time, the gluten free launch keeps the focus on brand reach in core soups.
- 📊 Watch how the Banza partnership translates into shelf space, volumes and pricing, especially given the current P/E of 10.4 versus a food industry average of about 15.6.
- ⚠️ The key flagged risk is that Campbell's debt is not well covered by operating cash flow, which matters if new products require sustained investment.
Dig Deeper
For the full picture including more risks and rewards, check out the complete Campbell's analysis. Alternatively, you can check out the community page for Campbell's to see how other investors believe this latest news will impact the company's narrative.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
